Headlands Research, a leading multinational network of clinical trial sites, has announced the acquisition of Clinvest Research, an established site based in Springfield, Missouri. Founded in 1996, Clinvest Research has conducted over 600 trials for chronic diseases and conditions such as headache and migraine, arthritis and chronic pain, and diabetes, as well as weight loss. “The acquisition of Clinvest Research strengthens our chronic pain and endocrinology expertise and increases participant access to clinical trials for highly prevalent diseases and conditions that often remain undiagnosed and untreated,” said Cathy Collins, CEO of Headlands Research.
Read the full article: Headlands Research Acquires Clinvest Research — the Clinical Research Site Network’s Third Addition of 2023 //
Source: https://www.businesswire.com/news/home/20230504005315/en/Headlands-Research-Acquires-Clinvest-Research-%E2%80%94-the-Clinical-Research-Site-Network%E2%80%99s-Third-Addition-of-2023